MDM Fundamental Analysis - MAISONS DU MONDE SA

Fundamental Rating

Overall MDM gets a fundamental rating of 3 out of 10. We evaluated MDM against 52 industry peers in the Specialty Retail industry. MDM may be in some trouble as it scores bad on both profitability and health. MDM is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

MDM had negative earnings in the past year.

MDM had a positive operating cash flow in the past year.

MDM had positive earnings in 4 of the past 5 years.

In the past 5 years MDM always reported a positive cash flow from operatings.

1.2 Ratios

With a Return On Assets value of -7.52%, MDM is not doing good in the industry: 75.00% of the companies in the same industry are doing better.

Looking at the Return On Equity, with a value of -23.13%, MDM is doing worse than 73.08% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-7.52%
ROE	-23.13%
ROIC	N/A

ROA(3y)-1.72%

ROA(5y)-0.18%

ROE(3y)-5.33%

ROE(5y)-0.77%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 65.54%, MDM belongs to the best of the industry, outperforming 94.23% of the companies in the same industry.

MDM's Gross Margin has been stable in the last couple of years.

MDM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	65.54%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.04%

GM growth 5Y-0.25%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

MDM does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for MDM remains at a similar level compared to 1 year ago.

Compared to 5 years ago, MDM has less shares outstanding

The debt/assets ratio for MDM is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.84, we must say that MDM is in the distress zone and has some risk of bankruptcy.

MDM has a Altman-Z score of 0.84. This is in the lower half of the industry: MDM underperforms 63.46% of its industry peers.

The Debt to FCF ratio of MDM is 4.88, which is a neutral value as it means it would take MDM, 4.88 years of fcf income to pay off all of its debts.

MDM has a Debt to FCF ratio (4.88) which is comparable to the rest of the industry.

A Debt/Equity ratio of 0.93 indicates that MDM is somewhat dependend on debt financing.

Looking at the Debt to Equity ratio, with a value of 0.93, MDM is doing worse than 73.08% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.93
Debt/FCF	4.88
Altman-Z	0.84

ROIC/WACCN/A

WACC3.38%

2.3 Liquidity

A Current Ratio of 0.72 indicates that MDM may have some problems paying its short term obligations.

With a Current ratio value of 0.72, MDM is not doing good in the industry: 84.62% of the companies in the same industry are doing better.

MDM has a Quick Ratio of 0.72. This is a bad value and indicates that MDM is not financially healthy enough and could expect problems in meeting its short term obligations.

The Quick ratio of MDM (0.32) is worse than 80.77% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.72
Quick Ratio	0.32

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

MDM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1531.94%.

MDM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.93%.

MDM shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.00% yearly.

EPS 1Y (TTM)-1531.94%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-1359.06%

Revenue 1Y (TTM)-10.93%

Revenue growth 3Y-8.7%

Revenue growth 5Y-4%

Sales Q2Q%-12.06%

3.2 Future

MDM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.05% yearly.

MDM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.54% yearly.

EPS Next Y6.31%

EPS Next 2Y35.9%

EPS Next 3Y27.67%

EPS Next 5Y23.05%

Revenue Next Year-5.43%

Revenue Next 2Y-1.39%

Revenue Next 3Y0.16%

Revenue Next 5Y0.54%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

MDM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year MDM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MDM is valued cheaply inside the industry as 92.31% of the companies are valued more expensively.

Based on the Price/Free Cash Flow ratio, MDM is valued cheaper than 100.00% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	0.66
EV/EBITDA	3.3

4.3 Compensation for Growth

MDM's earnings are expected to grow with 27.67% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y35.9%

EPS Next 3Y27.67%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for MDM!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MAISONS DU MONDE SA

EPA:MDM (7/18/2025, 7:00:00 PM)

2.4

+0.03 (+1.27%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Discretionary Distribution & Retail

GICS IndustrySpecialty Retail

Earnings (Last)05-15 2025-05-15

Earnings (Next)07-25 2025-07-25

Inst Owners49.09%

Inst Owner ChangeN/A

Ins Owners0.15%

Ins Owner ChangeN/A

Market Cap94.06M

Analysts50

Price Target3.16 (31.67%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0.06

Dividend Growth(5Y)-33.7%

DP-2.01%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-8.82%

PT rev (3m)-22.89%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-5.52%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.09
P/FCF	0.66
P/OCF	0.57
P/B	0.19
P/tB	21.75
EV/EBITDA	3.3

EPS(TTM)-3

EYN/A

EPS(NY)-0.53

Fwd EYN/A

FCF(TTM)3.64

FCFY151.72%

OCF(TTM)4.23

OCFY176.15%

SpS26.29

BVpS12.73

TBVpS0.11

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-7.52%
ROE	-23.13%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	65.54%
FCFM	13.85%

ROA(3y)-1.72%

ROA(5y)-0.18%

ROE(3y)-5.33%

ROE(5y)-0.77%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.04%

GM growth 5Y-0.25%

F-Score5

Asset Turnover0.67

Health

		Industry Rank	Sector Rank
Debt/Equity	0.93
Debt/FCF	4.88
Debt/EBITDA	2.25
Cap/Depr	10.12%
Cap/Sales	2.23%
Interest Coverage	N/A
Cash Conversion	80.16%
Profit Quality	N/A
Current Ratio	0.72
Quick Ratio	0.32
Altman-Z	0.84

F-Score5

WACC3.38%

ROIC/WACCN/A

Cap/Depr(3y)24.05%

Cap/Depr(5y)25.74%

Cap/Sales(3y)3.48%

Cap/Sales(5y)3.66%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-1531.94%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-1359.06%

EPS Next Y6.31%

EPS Next 2Y35.9%

EPS Next 3Y27.67%

EPS Next 5Y23.05%

Revenue 1Y (TTM)-10.93%

Revenue growth 3Y-8.7%

Revenue growth 5Y-4%

Sales Q2Q%-12.06%

Revenue Next Year-5.43%

Revenue Next 2Y-1.39%

Revenue Next 3Y0.16%

Revenue Next 5Y0.54%

EBIT growth 1Y-152.15%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year6424.15%

EBIT Next 3Y331.79%

EBIT Next 5Y200.53%

FCF growth 1Y-7.74%

FCF growth 3Y-11.59%

FCF growth 5Y-6.1%

OCF growth 1Y-12.21%

OCF growth 3Y-13.81%

OCF growth 5Y-8.3%

MAISONS DU MONDE SA (MDM.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens